Dynamic Technology Lab’s Vertex Pharmaceuticals VRTX Stock Holding History

Dynamic Technology Lab’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,154	Closed	-$541K	–	1393
2024 Q2	$541K	Buy	+1,154	New	+$501K	0.06%	482
2023 Q1	–	Sell	-7,140	Closed	-$2.06M	–	1538
2022 Q4	$2.06M	Buy	+7,140	New	+$2.18M	0.21%	130
2021 Q4	–	Sell	-7,831	Closed	-$1.42M	–	1524
2021 Q3	$1.42M	Buy	+7,831	New	+$1.53M	0.17%	159
2020 Q1	–	Sell	-1,108	Closed	-$243K	–	1402
2019 Q4	$243K	Sell	1,108 -2,077	-65%	-$420K	0.04%	768
2019 Q3	$540K	Buy	+3,185	New	+$563K	0.09%	388
2018 Q2	–	Sell	-1,446	Closed	-$235K	–	1351
2018 Q1	$235K	Buy	+1,446	New	+$236K	0.04%	831
2017 Q4	–	Sell	-3,519	Closed	-$535K	–	1369
2017 Q3	$535K	Sell	3,519 -1,561	-31%	-$235K	0.09%	411
2017 Q2	$654K	Buy	+5,080	New	+$612K	0.12%	259

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Dynamic Technology Lab's VRTX Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Vertex Pharmaceuticals (VRTX) in Q3 2024, closing a stake of 1,154 shares — an estimated $541K sold.

Dynamic Technology Lab first reported a position in VRTX in Q2 2017 and held it in 8 quarters. The position peaked at $2.06M in Q4 2022. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

Dynamic Technology Lab reported no remaining Vertex Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Dynamic Technology Lab sold 1,154 Vertex Pharmaceuticals shares in Q3 2024, an estimated $541K.
Dynamic Technology Lab first reported a position in Vertex Pharmaceuticals in Q2 2017 and held it in 8 quarters.
Dynamic Technology Lab's Vertex Pharmaceuticals position peaked at $2.06M in Q4 2022.
1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.